Sectors Up Close: 100% pharma tariff ‘more of a PR number’ | REUTERS

From Reuters.

Foreign-made drugs could soon face 100% US import tariffs, but that figure is likely an opening bid in negotiations — and there are still compelling ways to invest in healthcare, Impax Asset Management’s Nathan Moser says.
#News #Reuters #Newsfeed #markets #tariffs #trump

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en